This article is more than 5 years old. Information may no longer be current.
Transradial approach may be feasible in iliac disease
Transradial access was associated with a procedural success rate of nearly 99% in a cohort of patients with iliac disease, according to recent findings.
Currently, there is a paucity of data assessing the transradial approach in patients requiring intervention in peripheral areas like the iliac arteries. The aim of the multicenter study, which was conducted at five high-volume centers by clinicians experienced in this procedure, was to further investigate transradial access in iliac disease. The analysis included 149 patients who had medium risk profiles, 48% of whom had TASC 2 or 3 lesions.
Procedural success served as the primary endpoint. In-hospital bleeding, freedom from adverse events at 1 month and the rate of radial occlusion served as secondary endpoints. The researchers recorded contrast load and procedural and fluoroscopy times.
The procedural success rate was 98.7%. No in-hospital complications were reported, including both vascular access site and procedural complications. Clinicians used the ancillary transfemoral approach in 13% of the cohort.
Freedom from events at 1 month was reported in 97.3% of patients. Radial occlusion occurred in 2.7% of the population.
The use of a normal 6F or 7F introducer with a guiding catheter, TASC D lesion attempt, lesion length >30 mm and total occlusion were the main prognostic factors for an unsuccessful procedure.
“A transradial approach for iliac disease may be a feasible and safe alternative to the transfemoral route in experienced hands, in the light of significant technical improvements and dedicated devices,” the researchers concluded.
Disclosure: The researchers report no relevant financial disclosures.